Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Safety and Efficacy of DYNE-101 in Adults with DM1: Phase 1/2 ACHIEVE Trial Data

              Author:Wolf, Daniel   Bassez, Guillaume   Diaz-Manera, Jordi   Kools, Joost   Lilleker, James   Pane, Marika   Roxburgh, Richard   Schoser, Benedikt   Turner, Christopher   Mix, Chris   Ray, Soma   Han, Baoguang   Kerr, Douglas   Sansone, Valeria   

              Session Name:S16: Updates on Nerve and Muscle Disorders  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S16.003  

              Author Institution:Dyne Therapeutics, Inc., Waltham, MA  Institut de Myologie, Paris, France  Newcastle University, Newcastle, United Kingdom  Radboud University Medical Center, Nijmegen, Netherlands  Muscle Disease Unit, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom  Fondazione Policlinico Universitario A. Gemelli, Rome, Italy  Neurogenetics Clinic Centre for Brain Research, University of Auckland, Auckland, New Zealand  Friedrich-Baur-Institute, Dep. of Neurology LMU Clinics, Ludwig-Maximilians University, Munich, Germany  University College London Hospitals, London, United Kingdom  Centro Clinico NEMO, University of Milan, Milan, Italy